Associate Director, Discovery Biology
Tango Therapeutics
Boston, Massachusetts, United States
Kimberly Briggs studied biology at the College of William and Mary and received her PhD from the Cellular and Molecular Medicine program at the Johns Hopkins School of Medicine. Following her postdoctoral fellowship in the laboratory of Dr William G. Kaelin, Jr. at the Dana-Farber Cancer Institute, Dr Briggs joined the discovery biology group at Tango Therapeutics where she currently serves as the biology lead for the Tango PRMT5 programs.
Disclosure information not submitted.
Saturday, November 4, 2023
11:30 AM – 1:00 PM